Mills-Peninsula Health Services

Research at Sutter Health Brings New Hope to People With ALS

Posted on Jul 10, 2019 in Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, People, Quality, Research, Scroll Images, Sutter East Bay Medical Foundation

SAN FRANCISCO, Calif. — Stephen Hawking—one of the world’s most accomplished physicists— lived most of his life with amyotrophic lateral sclerosis (ALS). His lifetime of accomplishments and worldwide renown cast an international spotlight on the debilitating disease. Read More

New research by Sutter’s Center for Health Systems Research focused on fostering physician wellness

Posted on Jul 2, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Quality, Research, Scroll Images, Transformation

SAN FRANCISCO – How do you take care of those whose life’s work is to take care of others? “Physician, heal thyself” is an increasingly challenging objective to achieve for the more than 50% of American clinicians who report symptoms of burnout. Emotional exhaustion, depersonalization, depression and feelings of helplessness burden the care providers staffing primary and specialty clinics nationwide.

Read More

Mills-Peninsula Medical Center Receives Thrombectomy-Capable Stroke Center Certification

Posted on Jul 1, 2019 in Expanding Access, Mills-Peninsula Health Services, Quality, Scroll Images, Uncategorized

BURLINGAME, Calif. – Mills-Peninsula Medical Center (MPMC), part of the Sutter Health not-for-profit network, has received certification as a Thrombectomy-Capable Stroke Center (TSC) from The Joint Commission, in collaboration with the American Heart Association/American Stroke Association (AHA/ASA).

Read More

New digital health tool aims to help patients keep better tabs on diabetes

Posted on Jun 5, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Memorial Medical Center, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Research, Scroll Images

SAN FRANCISCO (Calif.) Type 2 diabetes is not curable, but it is controllable—but as any patient or doctor will tell you, managing diabetes comes with its own set of challenges.

Given the disease’s complexity, patients and doctors need to maximize their time together. To help improve the care of people with cardiometabolic conditions such as type 2 diabetes, hypertension, and high cholesterol, investigators in Sutter’s Center for Health Systems Research (CHSR) and collaborators at AstraZeneca Pharmaceuticals developed and piloted an online tool called CM-SHARE (cardiometabolic Sutter Health Advanced Reengineered Encounter) to help primary care providers better manage patients with diabetes and other cardiometabolic conditions during their office visits.

Read More

Shining Light on Multiple Sclerosis

Posted on May 30, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Research, Scroll Images, Transformation

SAN FRANCISCO, Calif. – Sutter researchers launch new digital health tool to improve care for people with multiple sclerosis

Multiple sclerosis (MS)—a potentially disabling immunologic disease of the central nervous system— affects more than 2.3 million people worldwide, including almost 1 million Americans. Despite new research and over a dozen treatments for MS, the specific cause remains unknown and the disease has no cure.

Read More

A New Lens to Study the Origin of Multiple Sclerosis

Posted on May 30, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Research, Scroll Images, Sutter East Bay Medical Foundation

SAN FRANCISCO, Calif. – A new research collaboration will allow Sutter to collect and analyze ‘big data’ in hopes of identifying new disease markers for Multiple Sclerosis (MS).

MS is a difficult disease to treat because its cause is unknown. 

“MS is challenging to manage because there are no biomarkers or blood tests to diagnose or understand the individual patient’s prognosis and his or her likely response to medications,” says Joanna Cooper, M.D., a Sutter neurologist and MS clinician-investigator. “We know that disease course and presentation of symptoms vary by gender, age, socioeconomic status, and ethnicity. But we don’t know which treatment would be optimal for which patients, and why.” Read More